Literature DB >> 11344359

Insect sting allergy with negative venom skin test responses.

D B Golden1, A Kagey-Sobotka, P S Norman, R G Hamilton, L M Lichtenstein.   

Abstract

BACKGROUND: In our 1976 controlled venom immuno rapy trial, 33% of 182 patients with a history of systemic reactions to insect stings were excluded because of negative venom skin test responses. There have been reports of patients with negative skin test responses who have had severe reactions to subsequent stings.
OBJECTIVE: Our aim is to increase awareness about the patient with a negative skin test response and insect sting allergy and to determine the frequency and significance of negative skin test responses in patients with a history of systemic reactions to insect stings.
METHODS: We prospectively examined the prevalence of negative venom skin test responses in patients with a history of systemic reactions to stings. In patients who gave informed consent, we analyzed the outcome of retesting and sting challenge.
RESULTS: Of 307 patients with positive histories screened for our sting challenge study, 208 (68%) had positive venom skin test responses (up to 1 microg/mL concentration), and 99 (32%) had negative venom skin test responses. In 36 (36%) of the 99 patients with negative skin test responses, the venom RAST result was a low positive (1-3 ng/mL), or repeat venom skin test responses were positive; another 7 (7%) patients had high venom-specific IgE antibody levels (4-243 ng/mL). Notably, 56 (57%) of 99 patients with positive histories and negative skin test responses had negative RAST results. In patients with positive skin test responses, sting challenges were performed in 141 of 196 patients, with 30 systemic reactions. Sting challenges were performed on 37 of 43 patients with negative skin test responses and positive venom-specific IgE and in 14 of 56 patients with negative skin test responses and negative RAST results. There were 11 patients with negative skin test responses who had systemic reactions to the challenge sting: 2 had negative RAST results, and 9 had positive RAST results at 1 ng/mL. The frequency of systemic reaction was 21% in patients with positive skin test responses and 22% in patients with negative skin test responses (24% in those with positive RAST results and 14% in those with negative RAST results).
CONCLUSIONS: Venom skin test responses can be negative in patients who will subsequently experience another systemic sting reaction. Venom skin test responses are negative in many patients with a history of systemic allergic reactions to insect stings and may be associated with positive serologic test responses for venom-specific IgE antibodies (sometimes strongly positive results). Venom skin test responses should be repeated when negative, along with a serologic IgE antivenom test. Better diagnostic skin test reagents are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344359     DOI: 10.1067/mai.2001.114706

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

1.  Insect stings: clinical features and management.

Authors:  Bernhard Przybilla; Franziska Ruëff
Journal:  Dtsch Arztebl Int       Date:  2012-03-30       Impact factor: 5.594

2.  Venom anaphylaxis.

Authors:  Jeffrey Alfonsi; Jason K Lee
Journal:  CMAJ       Date:  2015-06-08       Impact factor: 8.262

3.  [Standards and pitfalls of in-vitro diagnostics of Hymenoptera venom allergy].

Authors:  F Ruëff; U Jappe; B Przybilla
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

Review 4.  The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword.

Authors:  Jun Chen; William R Lariviere
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

Review 5.  Hymenoptera (apid and vespid) allergy: update in diagnosis and management.

Authors:  Gerald W Volcheck
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

6.  Bee- and Wasp-Venom Sensitization in Schoolchildren of High- and Low-Socioeconomic Status Living in an Urban Area of Indonesia.

Authors:  Aldian I Amaruddin; Jan Pieter R Koopman; Munawir Muhammad; Serge A Versteeg; Sitti Wahyuni; Ronald van Ree; Maria Yazdanbakhsh; Firdaus Hamid; Erliyani Sartono
Journal:  Int Arch Allergy Immunol       Date:  2021-05-05       Impact factor: 2.749

7.  The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.

Authors:  Theo Gülen; Barbro Dahlén; Birgitta Sander; Hans Hägglund; Gunnar Nilsson
Journal:  Clin Transl Allergy       Date:  2013-07-04       Impact factor: 5.871

8.  Bee venom pharmacopuncture responses according to sasang constitution and gender.

Authors:  Chaeweon Kim; Kwangho Lee
Journal:  J Pharmacopuncture       Date:  2013-12

9.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05

10.  Management of insect sting hypersensitivity: an update.

Authors:  Robert D Pesek; Richard F Lockey
Journal:  Allergy Asthma Immunol Res       Date:  2013-02-25       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.